Mitotic rate is a more reliable unfavorable prognosticator than ulceration for early cutaneous melanoma: A 5-year survival analysis

被引:21
|
作者
Donizy, Piotr [1 ]
Kaczorowski, Maciej [1 ]
Leskiewicz, Marek [2 ]
Zietek, Marcin [3 ]
Pieniazek, Malgorzata [4 ,5 ]
Kozyra, Cyprian [2 ]
Halon, Agnieszka [1 ]
Matkowski, Rafal [3 ,4 ,5 ]
机构
[1] Wroclaw Med Univ, Dept Pathomorphol & Oncol Cytol, PL-50556 Wroclaw, Poland
[2] Wroclaw Univ Econ, Dept Stat, PL-53345 Wroclaw, Poland
[3] Lower Silesian Oncol Ctr, PL-53413 Wroclaw, Poland
[4] Wroclaw Med Univ, Dept Oncol, PL-53413 Wroclaw, Poland
[5] Wroclaw Med Univ, Div Surg Oncol, PL-53413 Wroclaw, Poland
关键词
mitotic rate; ulceration; melanoma; prognosis; AMERICAN JOINT COMMITTEE; LYMPH-NODE POSITIVITY; CANCER STAGING SYSTEM; INVASION; PREDICTOR;
D O I
10.3892/or.2014.3531
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The presence of ulceration has been considered as one of the most important primary tumor characteristics of cutaneous malignant melanoma (CMM) for predicting patient outcome. Yet recently, scientific attention has been drawn towards another microscopic feature of primary tumors, the mitotic rate (MR). The present study aimed to examine the relationship between the presence of ulceration and the mitotic rate and clinicopathological characteristics and melanoma patient survival, and to discuss the results in the context of AJCC melanoma staging recommendations. Tissue samples were obtained from 104 patients treated for CMM. In classical H&E staining, the mitotic rate and the presence of ulceration were evaluated. Non-mitogenic tumors were defined as having 0 mitoses/mm(2), low mitogenic potential, 1-2 mitoses/mm(2) and highly mitogenic tumors, >= 3 mitoses/mm(2). In the entire group of 104 patients, a high mitotic rate (hMR) and ulceration were highly negative prognostic factors, and indicated considerably shorter overall survival, cancer-specific overall survival and disease-free survival. Notably, hMR appeared to have a statistically significant negative impact on survival in early melanomas in both the pT1 (P=0.001) and pT2 subgroups (P=0.006). Kaplan-Meier analysis of the remaining subsets (pT3 and pT4) did not reveal any important differences in the 5-year survival with regard to MR values. The presence of ulceration also had a prognostic significance for early melanomas, but only for pT1 tumors (P=0.05). Multivariate analysis confirmed that hMR was strongly associated with an unfavorable prognosis. Ulceration had no prognostic significance in the Cox proportional hazards model. Considering the biology of melanoma, hMR seems to be a more reliable parameter than the presence of ulceration. The value of MR categorizes melanomas into tumors with low or high proliferative potential, thus giving direct information concerning their capacity to infiltrate deeper layers of the dermis and, potentially, to generate regional lymph node and distant metastases.
引用
收藏
页码:2735 / 2743
页数:9
相关论文
共 48 条
  • [31] Comparison of Survival Rate between Posterior-Stabilized and Constrained Condylar Articulations in Revision Total Knee Arthroplasty: A Minimum 5-Year Follow-up Analysis
    Kwak, Woo-Kyoung
    Seon, Jong-Keun
    CLINICS IN ORTHOPEDIC SURGERY, 2023, 15 (04) : 589 - 596
  • [32] The long-term efficacy and safety of immunosuppressive therapy on the progression of IgA nephropathy: a meta-analysis of controlled clinical trials with more than 5-year follow-up
    Tian, Lei
    Shao, Xinghua
    Xie, Yuanyuan
    Wang, Ling
    Wang, Qin
    Che, Xiajing
    Ni, Zhaohui
    Mou, Shan
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (08) : 1137 - 1147
  • [33] Similar survival rate but lower functional outcomes following TKA in the elderly people compared to younger patients: analysis of a posterior stabilised implant with minimum 5-year follow-up
    Etienne Deroche
    Cécile Batailler
    Jobe Shatrov
    Stanislas Gunst
    Elvire Servien
    Sébastien Lustig
    Knee Surgery, Sports Traumatology, Arthroscopy, 2023, 31 : 1470 - 1476
  • [34] Similar survival rate but lower functional outcomes following TKA in the elderly people compared to younger patients: analysis of a posterior stabilised implant with minimum 5-year follow-up
    Deroche, Etienne
    Batailler, Cecile
    Shatrov, Jobe
    Gunst, Stanislas
    Servien, Elvire
    Lustig, Sebastien
    KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY, 2023, 31 (04) : 1470 - 1476
  • [35] Comparison of the more than 5-year clinical outcomes of cervical disc arthroplasty versus anterior cervical discectomy and fusion A protocol for a systematic review and meta-analysis of prospective randomized controlled trials
    Shao, Min-Min
    Chen, Chun-Hui
    Lin, Zhong-Ke
    Wang, Xiang-Yang
    Huang, Qi-Shan
    Chi, Yong-Long
    Wu, Ai-Min
    MEDICINE, 2016, 95 (51) : e5733
  • [36] Factors predicting overall survival (OS) and progression-free survival (PFS) in real-life: Classification and regression tree analysis of a 5-year (5Y) cohort follow-up study of advanced melanoma patients (pts) that have initiated pembrolizumab
    Saiag, P.
    Meyer, N.
    Dutriaux, C.
    Verdoni, L.
    Morsli, O.
    Spampinato, A.
    Lattenist, L.
    Mortier, L.
    Grob, J-J.
    ANNALS OF ONCOLOGY, 2020, 31 : S754 - S755
  • [37] Delivery mode and neonatal morbidity after remifentanil-PCA or epidural analgesia using the Ten Groups Classification System: A 5-year single-centre analysis of more than 10 000 deliveries
    Markova, Liljana
    Lucovnik, Miha
    Verdenik, Ivan
    Pintaric, Tatjana Stopar
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2022, 277 : 53 - 56
  • [38] Effect of progesterone on hCG day-to-basal progesterone ratio on live birth rate in long agonist fresh IVF/ICSI cycles: a 5-year, single-center study of more than 10,000 cycles
    Hu, Linli
    Xiong, Yujing
    Wang, Mengying
    Shi, Hao
    Sun, Yingpu
    GYNECOLOGICAL ENDOCRINOLOGY, 2021, 37 (08) : 706 - 710
  • [39] Actual 5-year survival of dose-dense sequential adjuvant chemotherapy in early breast cancer (BC) patients treated in the post-trastuzumab era: A pooled analysis of 3 clinical trials
    Fatorou, E. Aravantinou
    Koliou, G-A.
    Zagouri, F.
    Kostadima, L.
    Gogas, H.
    Pectasides, D.
    Binas, I.
    Koutras, A.
    Aravantinos, G.
    Psyrri, A.
    Lazaridis, G. L.
    Bafaloukos, D.
    Saloustros, E.
    Karanikiotis, C.
    Bombolaki, I. B.
    Razis, E.
    Koumarianou, A.
    Papakostas, P.
    Kosmidis, P.
    Fountzilas, G.
    ANNALS OF ONCOLOGY, 2020, 31 : S43 - S43
  • [40] Adjuvant dabrafenib plus trametinib (D plus T) versus placebo in patients with resected stage III BRAFV600-mutant melanoma: Updated 5-year distant metastases-free survival (DMFS) analysis of COMBI-AD.
    Schadendorf, Dirk
    Hauschild, Axel
    Mandala, Mario
    Kirkwood, John M.
    Robert, Caroline
    Grob, Jean-Jacques
    Nathan, Paul D.
    Davies, Michael A.
    Banerjee, Hiya
    Shah, Rohan
    Lau, Mike R.
    Dummer, Reinhard
    Long, Georgina V.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)